...
首页> 外文期刊>Anticancer Research: International Journal of Cancer Research and Treatment >Tumor-associated macrophage (TAM) infiltration in gastric cancer.
【24h】

Tumor-associated macrophage (TAM) infiltration in gastric cancer.

机译:胃癌中的肿瘤相关巨噬细胞(TAM)浸润。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Tumor-associated macrophages (TAMs) are defined as macrophages that migrate into the tumor stroma. TAMs are known to directly or indirectly affect immune suppression. TAMs have not previously been reported in gastric cancer. MATERIALS AND METHODS: Using anti-CD68 antibodies, we immunohistochemically evaluated TAM infiltration in 97 gastric cancer patients who underwent tumor resection. Furthermore, CD3-zeta chain expression of tumor infiltrating lymphocytes (TILs) from the same section was also examined. According to the degree of TAM infiltration, 97 patients were divided into two groups (high TAM group, more than 200 positive cells; low TAM group, less than 200 positive cells). Clarification of the clinicopathological features of TAM-positive gastric cancer was attempted. RESULTS: TAM infiltration in the tumor nest ranged from 0 to 621 cells (average 187). The degree of infiltration positively correlated with depth of invasion, nodal status and clinical stage. Patients in the high TAM group had lower CD3-zeta expression by TILs than patients in the low TAM group. CD3-zeta expression by TILs negatively correlated with infiltration of TAMs (p < 0.01). Patients with a high TAM count had poorer surgical outcomes than those with a low TAM count. CONCLUSION: From the results of the current study, TAM infiltration may be used as a prognostic marker in gastric cancer. Negative correlation between TAM infiltration and CD3-zeta expression by TILs suggests that TAMs may be responsible for the immunological inactivity of T cells in gastric cancer.
机译:背景:肿瘤相关巨噬细胞(TAM)被定义为迁移到肿瘤基质中的巨噬细胞。已知TAM直接或间接影响免疫抑制。 TAMs以前尚未在胃癌中报道。材料与方法:我们使用抗CD68抗体,通过免疫组织化学方法评估了97例接受肿瘤切除的胃癌患者中TAM的浸润情况。此外,还检查了同一切片中肿瘤浸润淋巴细胞(TILs)的CD3-ζ链表达。根据TAM浸润程度,将97例患者分为两组(高TAM组,阳性细胞超过200个;低TAM组,阳性细胞少于200个)。试图澄清TAM阳性胃癌的临床病理特征。结果:TAM在肿瘤巢中的浸润范围为0到621个细胞(平均187个)。浸润程度与浸润深度,淋巴结状态和临床分期呈正相关。高TAM组的患者的TILs的CD3-zeta表达低于低TAM组的患者。 TILs的CD3-zeta表达与TAM的浸润负相关(p <0.01)。 TAM计数高的患者比TAM计数低的患者的手术结果差。结论:根据目前的研究结果,TAM浸润可作为胃癌的预后指标。 TIL在TAM浸润和CD3-zeta表达之间的负相关性表明TAM可能是胃癌中T细胞免疫失活的原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号